ITGAX and nonpapillary renal cell carcinoma: Furthermore, to explore the expression of PD-1 in dendritic cells in tumor sections from ccRCC patients, we used the CD11c antibody (red) to label dendritic cells (Kvale et al., 2006) and performed immunofluorescence staining analysis with PD-1 antibody (green).